Zusammenfassung
Der Einsatz künstlicher Intelligenz (KI) wird derzeit in verschiedenen Bereichen der Medizin erforscht. In der Mammadiagnostik ist die Verwendung KI-gestützter Systeme bereits heute Realität, insbesondere in der Früherkennung. Dadurch wird erhofft, die Abläufe zu vereinfachen und den Untersucher durch eine automatisierte Einschätzung von Brustdichte und Malignitätsrisiko zu unterstützen. In der Mammasonographie wird der Einsatz der KI vor allem bei der automatisierten Sonographie (ABUS) untersucht. Auch eine Dignitätseinschätzung einer vom Untersucher angegebenen „region of interest“ auf dem B‑Bild wird durch die modernen Systeme ermöglicht. Darüber hinaus konnte die KI in der Magnetresonanztomographie (MRT) der Mamma zur Entwicklung eines hilfreichen Algorithmus beitragen. Der sog. Kaiser-Score steht dem Radiologen online zur Verfügung und hilft, das Malignitätsrisiko von MRT-Befunden einzuschätzen.
Abstract
The use of artificial intelligence (AI) is currently under investigation in various fields of medicine. In breast diagnostics the use of AI-guided systems is already reality, especially in the screening setting. It is hoped that in this way the workflow can be simplified and the radiologist can be supported through automatic assessment of the breast density and the risk of malignancy. The use of AI in breast ultrasound focuses mainly on automated breast ultrasound (ABUS). An estimation of the dignity of a region of interest selected by the investigator on a B-mode picture is also possible using modern systems. Furthermore, in magnetic resonance imaging (MRI) of the breast AI could contribute to the development of a useful algorithm. The so-called Kaiser score is available online for radiologists and helps to estimate the risk of malignancy from MRI findings.
Literatur
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.4, AWMF Registernummer: 032-045OL, http://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/. 2021.
Le EPV, Wang Y, Huang Y, Hickman S, Gilbert FJ (2019) Artificial intelligence in breast imaging. Clin Radiol 74(5):357–366
Evans A, Vinnicombe S (2017) Overdiagnosis in breast imaging. Breast 31:270–273
Elmore JG, Jackson SL, Abraham L, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Onega T, Rosenberg RD et al (2009) Variability in interpretive performance at screening mammography and radiologists’ characteristics associated with accuracy. Radiology 253(3):641–651
Patel AK (2021) Breast radiology advocacy: responding to the call-to-action. Radiol Clin North Am 59(1):13–17
Bennani-Baiti B, Baltzer PAT (2020) Künstliche Intelligenz in der Mammadiagnostik: Gestern, heute und morgen. Radiologe 60(1):56–63
Roehrig J, Doi T, Hasegawa A, Hunt B, Marschall J, Romsdahl H, Schneider A, Sharbaugh R, Zhang W (1998) Clinical results with R2 imagechecker system. In: Karssemeijer N, Thijssen M, Hendriks J, van Erning L (Hrsg) Digital mammography. Computational imaging and vision, Bd. 13. Springer, Dordrecht
Baltzer PAT (2021) Künstliche Intelligenz in der Mammadiagnostik. Radiologe 61:192–198
Lehman CD, Wellman RD, Buist DS, Kerlikowske K, Tosteson AN, Miglioretti DL, Breast Cancer Surveillance C (2015) Diagnostic accuracy of digital screening mammography with and without computer-aided detection. JAMA Intern Med 175(11):1828–1837
Moreira IC, Amaral I, Domingues I, Cardoso A, Cardoso MJ, Cardoso JS (2012) INbreast: toward a full-field digital mammographic database. Acad Radiol 19(2):236–248
Schaffter T, Buist DSM, Lee CI, Nikulin Y, Ribli D, Guan Y, Lotter W, Jie Z, Du H, Wang S et al (2020) Evaluation of combined artificial intelligence and radiologist assessment to interpret screening mammograms. JAMA Netw Open 3(3):e200265
Rodriguez-Ruiz A, Lang K, Gubern-Merida A, Broeders M, Gennaro G, Clauser P, Helbich TH, Chevalier M, Tan T, Mertelmeier T et al (2019) Stand-alone artificial intelligence for breast cancer detection in mammography: comparison with 101 radiologists. J Natl Cancer Inst 111(9):916–922
Sechopoulos I, Teuwen J, Mann R (2021) Artificial intelligence for breast cancer detection in mammography and digital breast tomosynthesis: state of the art. Semin Cancer Biol 72:214–225
McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H, Back T, Chesus M, Corrado GS, Darzi A et al (2020) International evaluation of an AI system for breast cancer screening. Nature 577(7788):89–94
Byng D, Strauch B, Gnas L, Leibig C, Stephan O, Bunk S, Hecht G (2022) AI-based prevention of interval cancers in a national mammography screening program. Eur J Radiol 152:110321
Kozegar E, Soryani M, Behnam H, Salamati M, Tan T (2020) Computer aided detection in automated 3‑D breast ultrasound images: a survey. Artif Intell Rev 53(3):1919–1941
Rella R, Belli P, Giuliani M, Bufi E, Carlino G, Rinaldi P, Manfredi R (2018) Automated breast ultrasonography (ABUS) in the screening and diagnostic setting: indications and practical use. Acad Radiol 25(11):1457–1470
Meng Z, Chen C, Zhu Y, Zhang S, Wei C, Hu B, Yu L, Hu B, Shen E (2015) Diagnostic performance of the automated breast volume scanner: a systematic review of inter-rater reliability/agreement and meta-analysis of diagnostic accuracy for differentiating benign and malignant breast lesions. Eur Radiol 25(12):3638–3647
An YY, Kim SH, Kang BJ (2015) The image quality and lesion characterization of breast using automated whole-breast ultrasound: a comparison with handheld ultrasound. Eur J Radiol 84(7):1232–1235
Jeh SK, Kim SH, Choi JJ, Jung SS, Choe BJ, Park S, Park MS (2016) Comparison of automated breast ultrasonography to handheld ultrasonography in detecting and diagnosing breast lesions. Acta Radiol 57(2):162–169
Chang JM, Moon WK, Cho N, Park JS, Kim SJ (2011) Radiologists’ performance in the detection of benign and malignant masses with 3D automated breast ultrasound (ABUS). Eur J Radiol 78(1):99–103
Brem RF, Tabar L, Duffy SW, Inciardi MF, Guingrich JA, Hashimoto BE, Lander MR, Lapidus RL, Peterson MK, Rapelyea JA et al (2015) Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study. Radiology 274(3):663–673
Giuliano V, Giuliano C (2013) Improved breast cancer detection in asymptomatic women using 3D-automated breast ultrasound in mammographically dense breasts. Clin Imaging 37(3):480–486
Kelly KM, Dean J, Comulada WS, Lee S‑J (2010) Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol 20(3):734–742
Wilczek B, Wilczek HE, Rasouliyan L, Leifland K (2016) Adding 3D automated breast ultrasound to mammography screening in women with heterogeneously and extremely dense breasts: Report from a hospital-based, high-volume, single-center breast cancer screening program. Eur J Radiol 85(9):1554–1563
Hatzipanagiotou ME, Huber D, Gerthofer V, Hetterich M, Ripoll BR, Ortmann O, Seitz S (2022) Feasibility of ABUS as an alternative to handheld ultrasound for response control in neoadjuvant breast cancer treatment. Clin Breast Cancer 22(2):e142–e146
Nicosia L, Addante F, Bozzini AC, Latronico A, Montesano M, Meneghetti L, Tettamanzi F, Frassoni S, Bagnardi V, De Santis R et al (2022) Evaluation of computer-aided diagnosis in breast ultrasonography: improvement in diagnostic performance of inexperienced radiologists. Clin Imaging 82:150–155
Wu JY, Zhao ZZ, Zhang WY, Liang M, Ou B, Yang HY, Luo BM (2019) Computer-aided diagnosis of solid breast lesions with ultrasound: factors associated with false-negative and false-positive results. J Ultrasound Med 38(12):3193–3202
Dietzel M, Baltzer PAT (2018) How to use the Kaiser score as a clinical decision rule for diagnosis in multiparametric breast MRI: a pictorial essay. Insights Imaging 9(3):325–335
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Banys-Paluchowski erhielt Honorare für Vorträge und Teilnahme an Advisory Boards von: Roche, Novartis, Pfizer, pfm, Eli Lilly, Onkowissen, Seagen, AstraZeneca, Eisai, AstraZeneca, Amgen, Samsung, MSD, GSK, Daiichi Sankyo, Gilead, Sirius Pintuition, Pierre Fabre, sowie Studienunterstützung von: EndoMag, Mammotome, MeritMedical. L. Dussan Molinos, M. Rübsamen, T. Töllner, A. Rody, T. Fehm, N. Bündgen und N. Krawczyk haben keine potenziellen Interessenkonflikte angegeben.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Redaktion
Jan Weichert, Lübeck
Ulrich Gembruch, Bonn
Klaus Diedrich, Lübeck
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Banys-Paluchowski, M., Dussan Molinos, L., Rübsamen, M. et al. Künstliche Intelligenz in der modernen Mammadiagnostik. Gynäkologie 55, 771–782 (2022). https://doi.org/10.1007/s00129-022-04997-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-022-04997-4
Schlüsselwörter
- Automatische Mustererkennung
- Diagnostische Techniken in Geburtshilfe und Gynäkologie
- Mammasonographie
- Mammakarzinom
- Screening